These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20002887)

  • 1. Inducible expression of (V600E) Braf using tyrosinase-driven Cre recombinase results in embryonic lethality.
    Dhomen N; Da Rocha Dias S; Hayward R; Ogilvie L; Hedley D; Delmas V; McCarthy A; Henderson D; Springer CJ; Pritchard C; Larue L; Marais R
    Pigment Cell Melanoma Res; 2010 Feb; 23(1):112-20. PubMed ID: 20002887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.
    Yu H; McDaid R; Lee J; Possik P; Li L; Kumar SM; Elder DE; Van Belle P; Gimotty P; Guerra M; Hammond R; Nathanson KL; Dalla Palma M; Herlyn M; Xu X
    Am J Pathol; 2009 Jun; 174(6):2367-77. PubMed ID: 19389934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human skin neural crest progenitor cells are susceptible to BRAF(V600E)-induced transformation.
    Kumar SM; Dai J; Li S; Yang R; Yu H; Nathanson KL; Liu S; Zhou H; Guo J; Xu X
    Oncogene; 2014 Feb; 33(7):832-41. PubMed ID: 23334329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53.
    Viros A; Sanchez-Laorden B; Pedersen M; Furney SJ; Rae J; Hogan K; Ejiama S; Girotti MR; Cook M; Dhomen N; Marais R
    Nature; 2014 Jul; 511(7510):478-482. PubMed ID: 24919155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice.
    Goel VK; Ibrahim N; Jiang G; Singhal M; Fee S; Flotte T; Westmoreland S; Haluska FS; Hinds PW; Haluska FG
    Oncogene; 2009 Jun; 28(23):2289-98. PubMed ID: 19398955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KLF9-dependent ROS regulate melanoma progression in stage-specific manner.
    Bagati A; Moparthy S; Fink EE; Bianchi-Smiraglia A; Yun DH; Kolesnikova M; Udartseva OO; Wolff DW; Roll MV; Lipchick BC; Han Z; Kozlova NI; Jowdy P; Berman AE; Box NF; Rodriguez C; Bshara W; Kandel ES; Soengas MS; Paragh G; Nikiforov MA
    Oncogene; 2019 May; 38(19):3585-3597. PubMed ID: 30664687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermal Delivery of Constructs Encoding Cre Recombinase to Induce Skin Tumors in Pten
    Deken MA; Song JY; Gadiot J; Bins AD; Kroon P; Verbrugge I; Blank CU
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation.
    Zingg D; Debbache J; Peña-Hernández R; Antunes AT; Schaefer SM; Cheng PF; Zimmerli D; Haeusel J; Calçada RR; Tuncer E; Zhang Y; Bossart R; Wong KK; Basler K; Dummer R; Santoro R; Levesque MP; Sommer L
    Cancer Cell; 2018 Jul; 34(1):69-84.e14. PubMed ID: 30008323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.
    McNeal AS; Liu K; Nakhate V; Natale CA; Duperret EK; Capell BC; Dentchev T; Berger SL; Herlyn M; Seykora JT; Ridky TW
    Cancer Discov; 2015 Oct; 5(10):1072-85. PubMed ID: 26183406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.
    Cheung M; Sharma A; Madhunapantula SV; Robertson GP
    Cancer Res; 2008 May; 68(9):3429-39. PubMed ID: 18451171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts.
    Mercer K; Giblett S; Green S; Lloyd D; DaRocha Dias S; Plumb M; Marais R; Pritchard C
    Cancer Res; 2005 Dec; 65(24):11493-500. PubMed ID: 16357158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic Braf induces melanocyte senescence and melanoma in mice.
    Dhomen N; Reis-Filho JS; da Rocha Dias S; Hayward R; Savage K; Delmas V; Larue L; Pritchard C; Marais R
    Cancer Cell; 2009 Apr; 15(4):294-303. PubMed ID: 19345328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OPN3 Regulates Melanogenesis in Human Congenital Melanocytic Nevus Cells through Functional Interaction with BRAF
    Dong X; Zeng W; Zhang W; Lan Y; Wang Y; Feng J; Gu L; Lu H
    J Invest Dermatol; 2022 Nov; 142(11):3020-3029.e5. PubMed ID: 35577105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival.
    Cartlidge RA; Thomas GR; Cagnol S; Jong KA; Molton SA; Finch AJ; McMahon M
    Pigment Cell Melanoma Res; 2008 Oct; 21(5):534-44. PubMed ID: 18715233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.
    Bonet C; Luciani F; Ottavi JF; Leclerc J; Jouenne FM; Boncompagni M; Bille K; Hofman V; Bossis G; Marco de Donatis G; Strub T; Cheli Y; Ohanna M; Luciano F; Marchetti S; Rocchi S; Birling MC; Avril MF; Poulalhon N; Luc T; Hofman P; Lacour JP; Davidson I; Bressac-de Paillerets B; Ballotti R; Marine JC; Bertolotto C
    J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Dietary Supplement Chondroitin-4-Sulfate Exhibits Oncogene-Specific Pro-tumor Effects on BRAF V600E Melanoma Cells.
    Lin R; Xia S; Shan C; Chen D; Liu Y; Gao X; Wang M; Kang HB; Pan Y; Liu S; Chung YR; Abdel-Wahab O; Merghoub T; Rossi M; Kudchadkar RR; Lawson DH; Khuri FR; Lonial S; Chen J
    Mol Cell; 2018 Mar; 69(6):923-937.e8. PubMed ID: 29547721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation.
    Kundu A; Quirit JG; Khouri MG; Firestone GL
    Mol Carcinog; 2017 Jan; 56(1):49-61. PubMed ID: 26878440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXQ1 controls the induced differentiation of melanocytic cells.
    Bagati A; Bianchi-Smiraglia A; Moparthy S; Kolesnikova K; Fink EE; Kolesnikova M; Roll MV; Jowdy P; Wolff DW; Polechetti A; Yun DH; Lipchick BC; Paul LM; Wrazen B; Moparthy K; Mudambi S; Morozevich GE; Georgieva SG; Wang J; Shafirstein G; Liu S; Kandel ES; Berman AE; Box NF; Paragh G; Nikiforov MA
    Cell Death Differ; 2018 Jun; 25(6):1040-1049. PubMed ID: 29463842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper Chelation Inhibits BRAF
    Brady DC; Crowe MS; Greenberg DN; Counter CM
    Cancer Res; 2017 Nov; 77(22):6240-6252. PubMed ID: 28986383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions.
    Busam KJ; Hedvat C; Pulitzer M; von Deimling A; Jungbluth AA
    Am J Surg Pathol; 2013 Mar; 37(3):413-20. PubMed ID: 23211290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.